文献速递浆细胞疾病

PKMYT1是del(17p)高危多发性骨髓瘤的可靶向弱点

PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma.
PubMed 文献 · Blood · 2026-01-01

该研究整合多发性骨髓瘤患者细胞的RNA测序数据与骨髓瘤细胞系的遗传依赖数据,发现WEE家族成员PKMYT1是携带del(17p)的骨髓瘤细胞的潜在治疗靶点。使用选择性抑制剂RP-6306或遗传抑制PKMYT1可导致DNA损伤积累、微核形成和有丝分裂灾难,优先杀伤del(17p)骨髓瘤细胞,并在体内模型中减轻肿瘤负荷、延长生存。

要点

  • PKMYT1是del(17p)多发性骨髓瘤的潜在可靶向弱点。
  • RP-6306抑制PKMYT1优先诱导del(17p)骨髓瘤细胞死亡。
  • PKMYT1抑制在体内模型中减轻肿瘤负荷并延长生存。

核心结论

  • PKMYT1是可靶向的弱点,支持将其抑制作为del(17p)或TP53缺陷多发性骨髓瘤的生物标志物驱动治疗策略。

研究设计与样本

  • 整合多发性骨髓瘤患者细胞的RNA测序数据与多发性骨髓瘤细胞系的遗传依赖数据。

主要发现

  • 遗传抑制或使用选择性抑制剂RP-6306药理学抑制PKMYT1活性,触发DNA损伤积累、微核形成和有丝分裂灾难。
  • 上述抑制优先导致del(17p)多发性骨髓瘤细胞死亡,而 largely 不伤害del(17p)阴性骨髓瘤细胞和健康细胞。
  • RP-6306在异种移植和TP53缺陷同基因模型中均减轻肿瘤负荷并延长生存。

临床怎么用

  • PKMYT1抑制可能作为del(17p)或TP53缺陷多发性骨髓瘤患者的生物标志物驱动治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deletion of chromosome 17p [del(17p)] is among the most adverse cytogenetic abnormalities in multiple myeloma (MM). By integrating RNA sequencing data from cells of patients with MM with genetic dependency data from MM cell lines, we identified protein kinase membrane-associated tyrosine/threonine 1 (PKMYT1), a member of the WEE family, as a potential therapeutic target in MM cells harboring del(17p). Genetic suppression or pharmacological inhibition of PKMYT1 activity with the selective inhibitor RP-6306 triggered accumulation of DNA damage, micronucleus formation, and mitotic catastrophe, resulting in preferential cell death in del(17p) MM cells while largely sparing del(17p)- MM cells and healthy cells. RP-6306 also reduced tumor burden and extended survival in vivo in both xenograft and TP53-deficient syngeneic models. Collectively, our findings nominate PKMYT1 as an actionable target and support PKMYT1 inhibition as a biomarker-driven therapeutic strategy for patients with del(17p) or TP53-deficient MM.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Schavgoulidze A, Cui J, Mayoral JE, et al. PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma. Blood. 2026. PMID: 42237635. doi:10.1182/blood.2026033819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。